Table 2.
Variable | Placebo | Caffeine | Mean Difference | 95% IC for the Difference | p |
---|---|---|---|---|---|
Mean Power (W) | 511 ± 113 | 521 ± 115 * | 10 | (5.3; 15.0) | 0.000 |
AA homozygotes | 494 ± 142 | 504 ± 140 | 9 | (–0.9; 18.5) | 0.120 |
C allele carriers | 516 ± 107 | 527 ± 110 * | 11 | (4.6; 16.4) | 0.002 |
Peak Power (W) | 663 ± 143 | 680 ± 146 * | 16 | (3.7; 29.0) | 0.014 |
AA homozygotes | 637 ± 200 | 646 ± 201 | 9 | (–0.9; 18.5) | 0.065 |
C allele carriers | 671 ± 128 | 690 ± 131 * | 19 | (1.9; 35.5) | 0.031 |
Fatigue index (%) | 44.2 ± 6.8 | 45.0 ± 7.2 | 0.8 | (–2.0; 3.6) | 0.571 |
AA homozygotes | 42.3 ± 6.5 | 42.2 ± 6.7 | –0.1 | (–2.1; 1.8) | 0.844 |
C allele carriers | 44.8 ± 7.0 | 45.9 ± 7.3 | 1.1 | (–2.7; 4.8) | 0.555 |
Perceived power | 6 ± 2 | 7 ± 2 | 1 | (–0.3; 1.7) | 0.158 |
AA homozygotes | 6 ± 2 | 7 ± 2 | 1 | (–2.6; 3.8) | 0.634 |
C allele carriers | 6 ± 2 | 7 ± 2 | 1 | (–0.4; 1.9) | 0.188 |
Perceived exertion | 6 ± 2 | 6 ± 2 | 0 | (–0.9; 1.1) | 0.836 |
AA homozygotes | 6 ± 1 | 6 ± 2 | 0 | (–2.2; 3.0) | 0.688 |
C allele carriers | 6 ± 2 | 6 ± 2 | 0 | (–1.2; 1.2) | 1.000 |
Data are mean ± SD for 21 healthy participants: AA homozygotes (n = 5) and C-allele carriers (n = 16). (*) Different from placebo condition (p < 0.05).